Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Viking Therapeutics (VKTX) Amortization - Intangibles: 2014-2018

Historic Amortization - Intangibles for Viking Therapeutics (VKTX) over the last 5 years, with Dec 2018 value amounting to $404,000.

  • Viking Therapeutics' Amortization - Intangibles fell 56.68% to $146,000 in Q2 2018 from the same period last year, while for Jun 2018 it was $919,000, marking a year-over-year decrease of 43.64%. This contributed to the annual value of $404,000 for FY2018, which is 68.51% down from last year.
  • Latest data reveals that Viking Therapeutics reported Amortization - Intangibles of $404,000 as of FY2018, which was down 68.51% from $1.3 million recorded in FY2017.
  • In the past 5 years, Viking Therapeutics' Amortization - Intangibles registered a high of $1.8 million during FY2016, and its lowest value of $404,000 during FY2018.
  • Over the past 3 years, Viking Therapeutics' median Amortization - Intangibles value was $1.3 million (recorded in 2017), while the average stood at $1.2 million.
  • In the last 5 years, Viking Therapeutics' Amortization - Intangibles soared by 100.12% in 2016 and then plummeted by 68.51% in 2018.
  • Over the past 5 years, Viking Therapeutics' Amortization - Intangibles (Yearly) stood at $557,961 in 2014, then surged by 60.14% to $893,502 in 2015, then spiked by 100.12% to $1.8 million in 2016, then dropped by 28.25% to $1.3 million in 2017, then slumped by 68.51% to $404,000 in 2018.